Actively Recruiting
Evaluation of Patients Who Underwent Revascularization of Aorta or Peripheral Artery at Asan Medical Center; Single Center Retrospective and Prospective Observational Study
Led by Asan Medical Center · Updated on 2024-07-17
6000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a single-center observational study to evaluate the clinical outcomes of patients who have undergone revascularization of the aorta or peripheral arteries at Asan Medical Center. This study includes both retrospective and prospective data collection on approximately 6,000 patients treated for conditions such as thoracic or abdominal aortic aneurysm, aortic dissection, penetrating aortic ulcer, and peripheral artery occlusive disease including chronic limb-threatening ischemia, claudication, and acute limb ischemia. The study collects data on treatments like EVAR, TEVAR, and PTA used for revascularization. Participants will be followed up through hospital visits or telephone calls at 1, 6, and 12 months, then at 3, 5, and up to 10 years after their procedures. The monitoring includes tracking major adverse limb events and any deaths. During follow-up visits, researchers will gather information on outcomes such as death from any cause, major adverse limb events, stroke, myocardial infarction, vascular complications, bleeding, procedure success, limb amputation, and the need for repeat interventions. The study aims to provide long-term clinical results over a 10-year period to better understand patient outcomes after these vascular procedures.
CONDITIONS
Brief Title
Asan Aorta and Peripheral Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who underwent revascularization of the aorta or peripheral artery since 2011 at Asan Medical Center
- Diagnosed with thoracic or abdominal aortic aneurysm, aortic dissection, or penetrating aortic ulcer
- Diagnosed with peripheral artery occlusive disease including chronic limb-threatening ischemia, claudication, or acute limb ischemia
You will not qualify if you...
- For prospective participants, not agreeing to participate by signing the informed consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Varies depending on individual treatment
Participants receive revascularization procedures such as EVAR, TEVAR, or PTA as part of routine care for aorta or peripheral artery disease.
Treatment occurs through routine healthcare
Duration - Up to 10 years
Participants are followed up to monitor clinical outcomes including major adverse limb events and survival.
Follow-up at 1, 6, and 12 months; 3, 5, and up to 10 years by telephone or hospital visit
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea
Actively Recruiting
Research Team
J
Jung hwa Lee, RN
S
Seung-Whan Lee
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here